210 related articles for article (PubMed ID: 24140549)
1. The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
Sakuraya K; Endo A; Someya T; Hirano D; Murano Y; Fujinaga S; Ohtomo Y; Shimizu T
J Urol; 2014 Apr; 191(4):1139-46. PubMed ID: 24140549
[TBL] [Abstract][Full Text] [Related]
2. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren.
Wu WP; Chang CH; Chiu YT; Ku CL; Wen MC; Shu KH; Wu MJ
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F929-41. PubMed ID: 20685818
[TBL] [Abstract][Full Text] [Related]
3. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.
Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW
J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401
[TBL] [Abstract][Full Text] [Related]
4. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.
Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS
PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620
[TBL] [Abstract][Full Text] [Related]
5. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effects of the direct renin inhibitor aliskiren on gentamicin-induced nephrotoxicity in rats.
Bae EH; Kim IJ; Joo SY; Kim EY; Choi JS; Kim CS; Ma SK; Lee J; Kim SW
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):348-61. PubMed ID: 23420778
[TBL] [Abstract][Full Text] [Related]
8. Functional and molecular evaluation of using aliskiren during acute and chronic partial ureteral obstruction in rat solitary kidney.
Essam M; Barakat N; Elkashef A; Awadalla A; Behery AE; Abdel-Maboud M
Life Sci; 2021 Jan; 265():118811. PubMed ID: 33259867
[TBL] [Abstract][Full Text] [Related]
9. Mizoribine ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
Sato N; Shiraiwa K; Kai K; Watanabe A; Ogawa S; Kobayashi Y; Yamagishi-Imai H; Utsunomiya Y; Mitarai T
Nephron; 2001 Oct; 89(2):177-85. PubMed ID: 11549900
[TBL] [Abstract][Full Text] [Related]
10. Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats.
Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Hyodo N; Suzuki S; Miura S
Nephrol Dial Transplant; 2005 Aug; 20(8):1573-81. PubMed ID: 15905195
[TBL] [Abstract][Full Text] [Related]
11. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
12. Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin.
Sakai T; Kawamura T; Shirasawa T
J Urol; 1997 Dec; 158(6):2316-22. PubMed ID: 9366383
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.
Elrashidy RA; Asker ME; Mohamed HE
J Pharm Pharmacol; 2012 Jun; 64(6):862-71. PubMed ID: 22571265
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren reduced renal fibrosis in mice with chronic ischemic kidney injury--beyond the direct renin inhibition.
Sun CY; Cherng WJ; Jian HZ; Hsu HH; Wu IW; Hsu HJ; Wu MS
Hypertens Res; 2012 Mar; 35(3):304-11. PubMed ID: 22089535
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis.
Wu MJ; Wen MC; Chiu YT; Chiou YY; Shu KH; Tang MJ
Kidney Int; 2006 Jun; 69(11):2029-36. PubMed ID: 16732193
[TBL] [Abstract][Full Text] [Related]
16. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
[TBL] [Abstract][Full Text] [Related]
17. Effects of paricalcitol and aliskiren combination therapy on experimental diabetic nephropathy model in rats.
Eren Z; Günal MY; Bakir EA; Coban J; Çağlayan B; Ekimci N; Ethemoglu S; Albayrak O; Akdeniz T; Demirel GY; Kiliç E; Kantarci G
Kidney Blood Press Res; 2014; 39(6):581-90. PubMed ID: 25532067
[TBL] [Abstract][Full Text] [Related]
18. Mizoribine suppresses the progression of experimental peritoneal fibrosis in a rat model.
Takahashi S; Taniguchi Y; Nakashima A; Arakawa T; Kawai T; Doi S; Ito T; Masaki T; Kohno N; Yorioka N
Nephron Exp Nephrol; 2009; 112(2):e59-69. PubMed ID: 19390220
[TBL] [Abstract][Full Text] [Related]
19. Renoprotective effects of aliskiren on adenine-induced tubulointerstitial nephropathy: possible underlying mechanisms.
Hussein AM; Malek HA; Saad MA
Can J Physiol Pharmacol; 2016 Aug; 94(8):829-37. PubMed ID: 27322834
[TBL] [Abstract][Full Text] [Related]
20. Role of Mesenchymal Stem Cells Transfected With Vascular Endothelial Growth Factor in Maintaining Renal Structure and Function in Rats with Unilateral Ureteral Obstruction.
Ozbek E; Adas G; Otunctemur A; Duruksu G; Koc B; Polat EC; Kemik Sarvan A; Okcu A; Kamali G; Subasi C; Karaoz E
Exp Clin Transplant; 2015 Jun; 13(3):262-72. PubMed ID: 25542189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
